136 related articles for article (PubMed ID: 2144018)
1. Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma.
Hrushesky WJ; von Roemeling R; Lanning RM; Rabatin JT
J Clin Oncol; 1990 Sep; 8(9):1504-13. PubMed ID: 2144018
[TBL] [Abstract][Full Text] [Related]
2. Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinoma.
Conroy T; Geoffrois L; Guillemin F; Luporsi E; Krakowski I; Spaëth D; Frasie V; Volff D
Cancer; 1993 Oct; 72(7):2190-7. PubMed ID: 8374877
[TBL] [Abstract][Full Text] [Related]
3. Circadian-based infusional chrono-chemotherapy controls progressive metastatic renal cell carcinoma.
Hrushesky WJ; Von Roemeling R; Fraley EE; Rabatin JT
Semin Surg Oncol; 1988; 4(2):110-5. PubMed ID: 2969133
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma.
Wilkinson MJ; Frye JW; Small EJ; Venook AP; Carroll PR; Ernest ML; Stagg RJ
Cancer; 1993 Jun; 71(11):3601-4. PubMed ID: 8490909
[TBL] [Abstract][Full Text] [Related]
5. Progressive metastatic renal cell carcinoma controlled by continuous 5-fluoro-2-deoxyuridine infusion.
von Roemeling R; Rabatin JT; Fraley EE; Hrushesky WJ
J Urol; 1988 Feb; 139(2):259-62. PubMed ID: 2963142
[TBL] [Abstract][Full Text] [Related]
6. Infusional floxuridine-based therapy for patients with metastatic renal cell carcinoma.
Reese DM; Corry M; Small EJ
Cancer; 2000 Mar; 88(6):1310-6. PubMed ID: 10717611
[TBL] [Abstract][Full Text] [Related]
7. Circadian-based infusional FUDR therapy.
Lanning RM; von Roemeling R; Hrushesky WJ
Oncol Nurs Forum; 1990; 17(1):49-56. PubMed ID: 2137216
[TBL] [Abstract][Full Text] [Related]
8. Treatment of metastatic renal cell carcinoma with constant-rate floxuridine infusion plus recombinant alpha 2b-interferon.
Falcone A; Cianci C; Pfanner E; Ricci S; Lencioni M; Brunetti I; Giulianotti PC; Vannucci L; Mosca F; Conte PF
Ann Oncol; 1996 Aug; 7(6):601-5. PubMed ID: 8879374
[TBL] [Abstract][Full Text] [Related]
9. Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer.
von Roemeling R; Hrushesky WJ
J Clin Oncol; 1989 Nov; 7(11):1710-9. PubMed ID: 2530318
[TBL] [Abstract][Full Text] [Related]
10. Continuous non chronomodulated infusion of floxuridine in metastatic renal cell carcinoma (MRCC): report of 17 cases.
Baiocchi C; Landonio G; Cacioppo C; Calgaro M; Cattaneo D; Ferrari M; Majno M
Tumori; 1996; 82(3):225-7. PubMed ID: 8693598
[TBL] [Abstract][Full Text] [Related]
11. Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump.
Damascelli B; Marchianò A; Spreafico C; Lutman R; Salvetti M; Bonalumi MG; Mauri M; Garbagnati F; Del Nero A; Comeri G
Cancer; 1990 Jul; 66(2):237-41. PubMed ID: 2142443
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
Hohn DC; Stagg RJ; Friedman MA; Hannigan JF; Rayner A; Ignoffo RJ; Acord P; Lewis BJ
J Clin Oncol; 1989 Nov; 7(11):1646-54. PubMed ID: 2530317
[TBL] [Abstract][Full Text] [Related]
13. [Adjuvant chemotherapy].
Del Nero A; Mandressi A; Longo G; Cogni M; Mangiarotti B; Buzzetti V; Russo R
Arch Ital Urol Nefrol Androl; 1991 Jun; 63(2):249-51. PubMed ID: 1830673
[TBL] [Abstract][Full Text] [Related]
14. Circadian infusion of floxuridine in patients with metastatic renal cell carcinoma.
Dexeus FH; Logothetis CJ; Sella A; Amato R; Kilbourn R; Ogden S; Striegel A; Kwan J; Newman RA
J Urol; 1991 Sep; 146(3):709-13. PubMed ID: 1831513
[TBL] [Abstract][Full Text] [Related]
15. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
Safi F; Bittner R; Roscher R; Schuhmacher K; Gaus W; Beger GH
Cancer; 1989 Jul; 64(2):379-87. PubMed ID: 2525415
[TBL] [Abstract][Full Text] [Related]
16. A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma.
Small EJ; Frye JW; Wilkinson MJ; Carroll PR; Ernest ML; Stagg RJ
Cancer; 1994 Jun; 73(11):2803-7. PubMed ID: 8194022
[TBL] [Abstract][Full Text] [Related]
17. Flexibility and efficacy of automatic continuous fluorodeoxyuridine infusion in metastases from a renal cell carcinoma.
Damascelli B; Marchianò A; Frigerio LF; Salvetti M; Spreafico C; Garbagnati F; Zanoni F; Radice F
Cancer; 1991 Sep; 68(5):995-8. PubMed ID: 1833043
[TBL] [Abstract][Full Text] [Related]
18. Alpha-2B-interferon plus floxuridine in metastatic renal cell carcinoma. A phase I-II study.
Falcone A; Cianci C; Ricci S; Brunetti I; Bertuccelli M; Conte PF
Cancer; 1993 Jul; 72(2):564-8. PubMed ID: 8319188
[TBL] [Abstract][Full Text] [Related]
19. [Continuous sinusoid systemic Fudr infusion in advanced colorectal carcinoma. Preliminary experience].
Civalleri D; Cavallini M; Tirindelli Danesi D; Decian F; Depaoli M; Balletto N
Minerva Chir; 1992 May; 47(9):853-8. PubMed ID: 1535695
[TBL] [Abstract][Full Text] [Related]
20. Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.
Lorenz M; Hottenrott C; Inglis R; Kirkowa-Reimann M
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3662-71. PubMed ID: 2531992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
